Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/63667COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Transcriptomic effects of tet-on and mifepristone-inducible systems in mouse liver |
Autor: | Reboredo, Mercedes; De Las Rivas, Javier CSIC ORCID CVN | Fecha de publicación: | 2008 | Editor: | Mary Ann Liebert | Citación: | Human Gene Therapy 19(11): 1233-1247 (2008) | Resumen: | Control of transgene expression from long-term expression vectors can be achieved with inducible and regulated promoters. The two most commonly used inducible systems employ doxycycline or mifepristone as the drug activating a silent trans-activator, which is expressed from a constitutive promoter. We evaluated the alterations provoked by constitutive expression in the liver of rtTA2S-M2 (rtTA2; second-generation reverse tetracycline-controlled trans-activator) and GLp65, which are the trans-activators of the doxycyline- and mifepristone-inducible systems, respectively. To this end we performed transcriptomic analysis of mice expressing these trans-activators in the liver over 1 month. rtTA2 expression induced alterations in a few genes (69 gene probesets; false discovery rate [FDR], ∼0.05), whereas GLp65 caused more numerous changes (1059 gene probe-sets, an FDR of ∼ 0.05). However, only 20 and 53 of the genes from the rtTA2 and GLp65 groups, respectively, showed changes (R-fold ≥ 3). Functional assignments indicate that alterations were mild and of little general significance. Few additional transcriptomic changes were observed when expressing trans-activators in the presence of inducer drugs; most were due to the drugs themselves. These results and the absence of toxicity observed in treated animals indicate that the two inducible systems are well tolerated and have little impact on the liver transcriptome profile. The milder alterations found with the use of rtTA2 suggest that this system is possibly safer for gene therapy applications. © Mary Ann Liebert, Inc. 2008. | Descripción: | 16 páginas, 6 figuras, 2 tablas.-- et al. | Versión del editor: | http:dx.doi.org/10.1089/hum.2008.057 | URI: | http://hdl.handle.net/10261/63667 | DOI: | 10.1089/hum.2008.057 | Identificadores: | doi: 10.1089/hum.2008.057 issn: 1043-0342 e-issn: 1557-7422 |
| Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Transcriptomic Effects.pdf | 463,22 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
5
checked on 12-abr-2024
SCOPUSTM
Citations
17
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
14
checked on 29-feb-2024
Page view(s)
338
checked on 19-abr-2024
Download(s)
323
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.